Employees: 506
Size Cosmecca Korea (241710.KS) is a South Korea Consumer Staples company (Household/Personal Care) with a market value of $847M, the 266th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩106,900 on 18 Nov 2026.
Performance Over six months the shares gained 23.3%, against +4.3% for the median peer and -37.2% for the South Korea market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 41.7% over the last twelve months (peer median +10.2%); the operating margin is 11.9% (peer median 8.9%).
Valuation It trades at 16.3× forward earnings against a peer median of 18.9× (7th cheapest of 20).
Capital Return on invested capital runs 8.1 points above its cost of capital (5.3% WACC).
Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩837B | ₩641B | ₩524B | ₩471B | ₩399B |
| Revenue growth | — | +22% | +11% | +18% | — |
| Gross profit | ₩183B | ₩155B | ₩119B | ₩102B | ₩59.8B |
| EBITDA | ₩119B | ₩100B | ₩78.2B | ₩65.8B | ₩27.1B |
| Net income | ₩58.0B | ₩45.4B | ₩42.8B | ₩22.3B | ₩2.66B |
| Free cash flow | -₩6.22B | -₩6.34B | ₩20.8B | ₩23.4B | ₩5.12B |
| Capital expenditure | ₩53.9B | ₩61.5B | ₩49.0B | ₩18.7B | ₩11.8B |
| Total debt | ₩260B | ₩172B | ₩122B | ₩109B | ₩121B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 241710.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -0.6% | -3.5% | 9th highest of 21 |
| 6-month return | +23.3% | +4.3% | 5th highest of 21 |
| Distance from 52-week high | -31.2% | -33.1% | 11th highest of 21 |
| Revenue growth (TTM) | +41.7% | +10.2% | 3rd highest of 21 |
| Operating margin | 11.9% | 8.9% | 8th highest of 21 |
| Forward P/E | 16.3× | 18.9× | 7th cheapest of 20 |
| ROIC minus cost of capital | +8.1 pp | +6.2 pp | 10th highest of 21 |
| EV / EBITDA | 11.4× | 9.6× | 3rd most expensive of 13 |
| Net debt / EBITDA | 1.4× | -1.1× | 2nd most indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| AMOREPACIFIC 002790.KS | South Korea | $1.61B | +2% | +9% | 9% | 8.5× | -5.7% | -1.3% |